P902: ISATUXIMAB, WEEKLY CARFILZOMIB AND DEXAMETHASONE AS SALVAGE THERAPY FOR RRMM; INTERIM RESULTS FROM A PHASE 2 TRIAL.

por Vesole, David H., Berdeja, Jesus, Matous, Jeffrey, Trudel, Suzanne, Schade, Henning, Munster, Pamela, Berkeley, Savannah, Sun, Benjamin, Martin, Tom
Publicado 2023

Oprozomib in patients with newly diagnosed multiple myeloma

por Hari, Parameswaran, Matous, Jeffrey V., Voorhees, Peter M., Shain, Kenneth H., Obreja, Mihaela, Frye, John, Fujii, Hisaki, Jakubowiak, Andrzej J., Rossi, Davide, Sonneveld, Pieter
Publicado 2019

A phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed/refractory multiple myeloma: Final analysis of second dose‐expansion coh...

por Berdeja, Jesus G., Gregory, Tara K., Faber, Edward A., Hart, Lowell L., Mace, Joseph R., Arrowsmith, Edward R., Flinn, Ian W., Matous, Jeffrey V.
Publicado 2021

Brentuximab vedotin, an antibody–drug conjugate, in patients with CD30‐positive haematologic malignancies and hepatic or renal impairment

por Zhao, Baiteng, Chen, Robert, O'Connor, Owen A., Gopal, Ajay K., Ramchandren, Radhakrishnan, Goy, Andre, Matous, Jeffrey V., Fasanmade, Adedigbo A., Manley, Thomas J., Han, Tae H.
Publicado 2016

S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY

por Offner, Fritz, Decaux, Olivier, Hulin, Cyrille, Anguille, Sébastien, Sophie Michallet, Anne, Costa, Luciano, Touzeau, Cyrille, Boyd, Kevin, Vishwamitra, Deeksha, Guo, Yue, Niu, Zhuolu, Larsen, Julie, Chen, Lingling, Banerjee, Arnob, Goldberg, Jenna, Matous, Jeffrey
Publicado 2023

Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies

por Bartlett, Nancy L, Chen, Robert, Fanale, Michelle A, Brice, Pauline, Gopal, Ajay, Smith, Scott E, Advani, Ranjana, Matous, Jeffrey V, Ramchandren, Radhakrishnan, Rosenblatt, Joseph D, Huebner, Dirk, Levine, Pamela, Grove, Laurie, Forero-Torres, Andres
Publicado 2014

Population pharmacokinetics of pomalidomide in patients with relapsed or refractory multiple myeloma with various degrees of impaired renal function

por Li, Yan, Wang, Xiaomin, O’Mara, Edward, Dimopoulos, Meletios A, Sonneveld, Pieter, Weisel, Katja C, Matous, Jeffrey, Siegel, David S, Shah, Jatin J, Kueenburg, Elisabeth, Sternas, Lars, Cavanaugh, Chloe, Zaki, Mohamed, Palmisano, Maria, Zhou, Simon
Publicado 2017

Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III Innovate(TM) Trial

por Trotman, Judith, Buske, Christian, Tedeschi, Alessandra, Matous, Jeffrey V., MacDonald, David, Tam, Constantine S., Tournilhac, Olivier, Ma, Shuo, Treon, Steven P., Oriol, Albert, Ping, Jerry, Briso, Eva M., Arango-Hisijara, Israel, Dimopoulos, Meletios A.
Publicado 2021

Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma

por Chari, Ajai, Cornell, Robert F., Gasparetto, Cristina, Karanes, Chatchada, Matous, Jeffrey V., Niesvizky, Ruben, Lunning, Matthew, Usmani, Saad Z., Anderson, Larry D., Chhabra, Saurabh, Girnius, Saulius, Shustik, Chaim, Stuart, Robert, Lee, Yihua, Salman, Zeena, Liu, Emily, Valent, Jason
Publicado 2020

P882: POMALIDOMIDE, DARATUMUMAB, AND DEXAMETHASONE AFTER LENALIDOMIDE TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): FINAL OVERALL SURVIVAL ANALYSIS OF...

por Bahlis, Nizar J, Samaras, Christy, Reece, Donna, Sebag, Michael, Matous, Jeffrey, Berdeja, Jesus, Shustik, Jesse, Schiller, Gary, Ganguly, Siddhartha, Song, Kevin, Seet, Christopher S., Acosta-Rivera, Mirelis, Quick, Donald, Anz, Bertrand, Fonseca, Gustavo, Flores, Unicel-Anne, Liu, Hongjuan, Gentili, Christian, Siegel, David
Publicado 2023

Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma

por Chen, Christine, Reece, Donna E, Siegel, David, Niesvizky, Ruben, Boccia, Ralph V, Stadtmauer, Edward A, Abonour, Rafat, Richardson, Paul, Matous, Jeffrey, Kumar, Shaji, Bahlis, Nizar J, Alsina, Melissa, Vescio, Robert, Coutre, Steven E, Pietronigro, Dennis, Knight, Robert D, Zeldis, Jerome B, Rajkumar, Vincent
Publicado 2009

P865: TECLISTAMAB IN COMBINATION WITH LENALIDOMIDE IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA IN THE PHASE 1B MULTICOHORT MAJESTEC-2 STUDY

por Tan, Carlyn, Searle, Emma, Anguille, Sébastien, Bhutani, Manisha, Biran, Noa, Boyd, Kevin, Cowan, Andrew, Matous, Jeffrey, Perrot, Aurore, Berdeja, Jesus, Janowski, Wojciech, Popat, Rakesh, Quach, Hang, Schroeder, Mark, Wong, Sandy W, Vishwamitra, Deeksha, Guo, Yue, Niu, Zhuolu, Larsen, Julie, Chen, Lingling, Banerjee, Arnob, Touzeau, Cyrille
Publicado 2023

PB2122: A PHASE 1/2 MULTI-CENTER, DOSE-FINDING STUDY INVESTIGATING THE SAFETY, TOLERABILITY, PK AND EFFICACY OF ZN-D5, A NOVEL BCL-2 INHIBITOR, IN PATIENTS WITH RELAPSED/REFRACTORY...

por Kastritis, Efstathios, Matous, Jeffrey, Berdeja, Jesus, Abro, Emad, Augustson, Bradley, Perianes, Valentin Cabañas, Cibeira, M. Theresa, Cohen, Yael, Fong, Michael, Gatt, Moshe, DE LA Calle, Veronica Gonzalez, Kwok, Fiona, Lavi, Noa, Magen, Hila, Oriol, Albert, Palladini, Giovanni, Stockerl-Goldstein, Keith, Eves, Taylor, Zheng, Cheng, Fiorino, Anthony
Publicado 2023

Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment

por Siegel, David S., Schiller, Gary J., Samaras, Christy, Sebag, Michael, Berdeja, Jesus, Ganguly, Siddhartha, Matous, Jeffrey, Song, Kevin, Seet, Christopher S., Talamo, Giampaolo, Acosta-Rivera, Mirelis, Bar, Michael, Quick, Donald, Anz, Bertrand, Fonseca, Gustavo, Reece, Donna, Pierceall, William E., Chung, Weiyuan, Zafar, Faiza, Agarwal, Amit, Bahlis, Nizar J.
Publicado 2020

Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study

por Buske, Christian, Tedeschi, Alessandra, Trotman, Judith, García-Sanz, Ramón, MacDonald, David, Leblond, Veronique, Mahe, Beatrice, Herbaux, Charles, Matous, Jeffrey V., Tam, Constantine S., Heffner, Leonard T., Varettoni, Marzia, Palomba, M. Lia, Shustik, Chaim, Kastritis, Efstathios, Treon, Steven P., Ping, Jerry, Hauns, Bernhard, Arango-Hisijara, Israel, Dimopoulos, Meletios A.
Publicado 2022